Skin Cancer Gains Spotlight As House Passes Sunscreen Innovation Act

FDA's top official is emphasizing recent agency actions to prevent skin cancer through sunscreen labeling and sunlamp regulation in the wake of the House's recent passage of legislation that would clear a backlog of sunscreen ingredient submissions at FDA and as the U.S. Surgeon General issues a call to action on skin cancer prevention. The Sunscreen Innovation Act, which would clear a backlog of sunscreen submissions withing eight months and require FDA review new submissions within an 11-month timeframe, passed...